HTCTF yields 6.15% · JNJ yields 2.13%● Live data
📍 HTCTF pulled ahead of the other in Year 1
Combined, HTCTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HTCTF + JNJ for your $10,000?
Hutchison Telecommunications Hong Kong Holdings Limited, an investment holding company, provides mobile communication services. It offers 5G, 4G long term evolution, 3G, and GSM dual-band mobile telecommunications under the 3 brand. The company also provides mobile telecommunications services and products include local voice, SMS, MMS, international direct dialing, and international roaming; and data services and applications, such as direct carrier billing offerings, mobile device security management, eBooks, music downloads, movies-on-demand, mobile social networking applications, and FinTech, as well as Wi-Fi and other value-added services. In addition, the company is involved in the provision of marketing, advertising, and promotional services; and telecommunications retail operations. As of December 31, 2021, it served approximately 3.2 million customers in Hong Kong and Macau. The company was incorporated in 2007 and is headquartered in Central, Hong Kong. Hutchison Telecommunications Hong Kong Holdings Limited is a subsidiary of CK Hutchison Holdings Limited.
Full HTCTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.